ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Dallas, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Stomach Cancer
Cancer
Ovarian Cancer
Neoplasm Metastasis
Breast Cancer

Pancreatic Cancer trials near Dallas, TX, USA:

Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic Cancer

SGT-53 and gemcitabine/nab-paclitaxel in patients with metastatic pancreatic cancer. The objective of the study is to evaluate the ...

Active, not recruiting
Metastatic Pancreatic Cancer
Drug: Gemcitabine
Genetic: SGT-53

Phase 2

SynerGene Therapeutics

Dallas, Texas, United States of America

open label, multi-center, clinical study of Chimeric Antigen Receptor T Cells (CAR-T) targeting claudin18.2 in patients with advanced gastric, pancreatic...

Active, not recruiting
Gastric Cancer
Pancreatic Cancer
Biological: CT041

Phase 1, Phase 2

CARsgen Therapeutics

Dallas, Texas, United States and 15 other locations

Subjects will be offered the opportunity to participate in a randomized, controlled, 2-arm, unblinded multicenter trial (RCT). There will be 2 study...

Active, not recruiting
Stage III Pancreatic Cancer
Drug: Modified FOLFIRINOX Regimen
Device: NanoKnife System

Phase 3

AngioDynamics
AngioDynamics

Dallas, Texas, United States and 5 other locations

the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of XNW28012 Monotherapy in the Treatment of Subjects with Metastatic Pancreatic...

Not yet enrolling
Metastatic Pancreatic Cancer
Drug: XNW28012

Phase 1

Evopoint Biosciences

Dallas, Texas, United States and 7 other locations

Pancreatic cancer is difficult to diagnose early. By the time people have been diagnosed, the cancer has usually spread to ...

Enrolling
Metastatic Pancreatic Adenocarcinoma
Metastatic Pancreatic Cancer
Drug: Oxaliplatin
Drug: Leucovorin

Phase 3

Astellas
Astellas

Dallas, Texas, United States and 78 other locations

study will assess the safety and efficacy of VS-7375 alone and in combination with cetuximab in patients with metastatic KRAS G12D - mutated Pancreatic...

Enrolling
Pancreatic Ductal Adenocarcinoma (PDAC)
G12D Mutated KRAS
Drug: VS-7375
Drug: cetuximab

Phase 2

Verastem

Fort Worth, Texas, United States and 28 other locations

This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread...

Enrolling
Metastatic Pancreatic Carcinoma
Stage IV Pancreatic Cancer AJCC v8
Drug: Pemigatinib
Procedure: Bone Scan

Phase 2

Sameek Roychowdhury

Dallas, Texas, United States and 108 other locations

phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety...

Active, not recruiting
Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 1

Amgen
Amgen

Irving, Texas, United States and 76 other locations

TNG462-C102 is a Phase 1/2, open-label, multicenter study designed to determine the safety, tolerability, PK, PD, and preliminary antineoplastic acti...

Enrolling
Pancreatic Cancer Metastatic
PDAC - Pancreatic Ductal Adenocarcinoma
Drug: TNG462
Drug: gemcitabine/nab-paclitaxel

Phase 1, Phase 2

Tango Therapeutics
Tango Therapeutics

Irving, Texas, United States and 17 other locations

The purpose of this study is to evaluate the safety and efficacy of an investigational RAS(ON) inhibitor administered as monotherapy or in combinatio...

Enrolling
Pancreatic Cancer Metastatic
Pancreatic Adenocarcinoma Metastatic
Drug: daraxonrasib
Drug: nab-paclitaxel

Phase 3

Revolution Medicines
Revolution Medicines

Dallas, Texas, United States and 48 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems